Champions Oncology, Inc. CSBR
NASDAQ · United States · Health Technology
$4.94+0.06 (+1.23%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-09-10 | 0.05 | -0.01 | +600.0% | $15.23M | +1.2% | +1.8%$5.01→$5.10 |
| Q2 2026 | 2025-12-15 | 0.06 | 0.00 | — | — | — | +0.1%$6.72→$6.73 |
| Q3 2025 | 2025-03-11 | 0.33 | -0.01 | +3,400.0% | — | — | — |
| Q2 2025 | 2024-12-11 | 0.05 | 0.01 | +400.0% | — | — | — |
| Q1 2025 | 2024-09-11 | 0.11 | -0.03 | +466.7% | — | — | — |
| Q4 2024 | 2024-07-18 | 0.01 | -0.16 | +106.3% | — | — | — |
| Q3 2024 | 2024-03-12 | -0.16 | -0.06 | -166.7% | — | — | — |
| Q2 2024 | 2023-12-12 | -0.15 | -0.16 | +6.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.